Farallon Capital Management
http://www.faralloncapital.com/farallon/index.htmFarallon Capital Management is an investment firm than manages equity capital for institutions and high net worth individuals. The firm's institutional investors are primarily college endowments and foundations. Farallon primarily invests in businesses and securities that are undergoing change or will appreciate because of an expected event which includes mergers, restructurings, recapitalizations or other major changes. The firm seeks to build strong relationships with the management of companies in which it invests.
View Older Stories View More Recent Stories
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-NT Farallon Capital Europe For: Mar 31
-
Alvotech Improves Access to Capital and Streamlines Path to Expected Public Listing on NASDAQ Stock Exchange
-
Alfa Laval to acquire Desmet, a world leader in edible oil and biofuel processing
-
Toshiba's spin-off plan up against much opposition at Thursday's shareholder vote
-
Clint Carnell Named CEO of InBrace
-
Exclusive-Activist fund Oasis backs call for Toshiba to solicit buyout offers -source
-
Toshiba's spin-off plan faces much opposition at pivotal shareholder vote
-
In break with Toshiba board, director says to back plan that could open door to buyout
-
Form D/A Farallon Capital Partner
-
Form D/A Farallon Capital Institu
-
Form D/A Farallon Capital (AM)
-
Form D/A FARALLON CAPITAL OFFSHOR
-
Major Toshiba shareholder Farallon calls on it to solicit buy-out offers
-
Farallon Urges Toshiba to Solicit Privatization Proposals and Announces Voting Intentions
-
Form SC 13G AMYRIS, INC. Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Beta Bionics Announces Closing of $57 Million Series C Financing
-
Beta Bionics Announces Closing of $57 Million Series C Financing
-
Form SC 13G/A Swiftmerge Acquisition Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Clever Leaves Holdings Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Metals Acquisition Corp Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-NT Farallon Capital Europe For: Dec 31
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Dec 31
-
Form SC 13G/A Protagonist Therapeutics Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Solid Power, Inc. Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A ENANTA PHARMACEUTICALS Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Caribou Biosciences, Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A AMYRIS, INC. Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Ada Health extends Series B to $120 million to accelerate rapid growth
-
Form SC 13G/A Better Therapeutics, Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Mercury Ecommerce Acquis Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Shelter Acquisition Corp Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Inflection Point Acquisi Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A SDCL EDGE Acquisition Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Savara Inc. Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Nextdoor Holdings, Inc. Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Marblegate Acquisition Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A BioAtla, Inc. Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Aramark Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Disruptive Acquisition Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Generation Bio Co. Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Imago BioSciences, Inc. Filed by: FARALLON CAPITAL MANAGEMENT LLC

